The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorChildren's National Research Institute
About this trial
The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are:
1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?
Eligibility criteria
Qualifiers
Primary caregiver of the child with asthma seen at the community-based asthma clinic
Female (self-identified)
Black (self-identified)
≥ 18 years of age
Disqualifiers
Acutely suicidal (high risk on the C-SSRS at child's asthma clinic visit)
Bipolar disorder or mania
Schizophrenia
Current substance abuse/dependence
Trial design
Treatments tested in this trial
- Enhanced Brief Interpersonal Psychotherapy
- Supplemented Usual Care
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Children's National Research Institute
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Source ClinicalTrials.gov